Skip to main content
IMUGENE LIMITED logo

IMUGENE LIMITED — Investor Relations & Filings

Ticker · IMU ISIN · AU000000IMU9 LEI · 984500A5C9KF08EAF248 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,442 across all filing types
Latest filing 2022-12-04 Regulatory Filings
Country AU Australia
Listing ASX IMU

About IMUGENE LIMITED

https://imugene.com

Imugene Limited is a clinical-stage immuno-oncology company focused on developing immunotherapies to activate the immune system against various cancers. The company’s pipeline features multiple platform technologies, including B-cell activating immunotherapies, oncolytic viruses, and CAR-T cell enhancement therapies. Key clinical candidates include HER-Vaxx, targeting HER2-positive gastric cancer, and PD1-Vaxx, a checkpoint inhibitor immunotherapy. Imugene is also advancing the CF33 oncolytic virus platform, which includes VAXINIA and CHECKvacc, alongside the onCARlytics program. The onCARlytics platform is designed to enable CAR-T cells to target solid tumors by inducing the expression of CD19 on cancer cell surfaces. These programs aim to address unmet needs in oncology by providing targeted, potent, and potentially less toxic alternatives to conventional treatments.

Recent filings

Filing Released Lang Actions
Appendix 2A 21 pages 396.0KB
Regulatory Filings Classification · 100% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX (Australian Securities Exchange). It details the issuance and quotation of securities resulting from options exercised or convertible securities converted. The document is a regulatory announcement related to securities quotation and issuance, not a financial report, earnings release, or management discussion. It is a formal regulatory filing to the exchange about securities quotation, consistent with ASX Listing Rule requirements. Therefore, it fits best under the category of Regulatory Filings (RNS), as it is a compliance announcement and does not contain financial statements or management commentary.
2022-12-04 English
Notice Under Section 708A 1 page 162.8KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement titled 'Notice Under Section 708A(5) of the Corporations Act 2001'. It provides details about the issuance of shares by Imugene Limited, including the number of shares issued, issue price, and compliance statements under the Corporations Act. The content is a formal notification regarding a capital raising event without disclosure under Part 6D.2 of the Corporations Act. It does not contain financial statements or detailed financial analysis but is an update on the company's capital structure. Given the nature of the notice about share issuance and compliance, this fits the category of Capital/Financing Update (CAP). The document length is short and it is not a report publication announcement or certification. Therefore, the appropriate classification is CAP with high confidence.
2022-12-04 English
Application for quotation of securities - IMU 7 pages 28.8KB
Share Issue/Capital Change Classification · 100% confidence The document is an application for quotation of securities on the ASX, detailing the issuance and conversion of options into ordinary fully paid shares. It includes specifics about the number of securities, issue dates, and the nature of the securities being quoted. This type of document is related to changes in the company's capital structure, specifically the issuance and quotation of new shares resulting from option exercises. It is not a financial report, earnings release, or management discussion, nor is it a regulatory announcement about voting or board changes. The document fits the category of announcements regarding new share issues or capital changes.
2022-11-24 English
Application for quotation of securities - IMU 7 pages 28.7KB
Share Issue/Capital Change Classification · 100% confidence The document is an application for quotation of securities on the ASX, detailing the issuance and conversion of options into ordinary fully paid shares. It includes specifics about the number of securities, issue dates, and classifications of securities. This type of document is related to changes in the company's capital structure, specifically the issuance and quotation of new shares resulting from option exercises. It is not a financial report, earnings release, or management discussion, nor is it a regulatory certification or announcement of a report publication. The content aligns with announcements about capital changes or share issues.
2022-11-17 English
AGM Presentation 15 pages 3.1MB
AGM Information Classification · 95% confidence The document is a detailed presentation titled 'AGM November 2022' and contains extensive information about the company's clinical trials, management team, investment highlights, and year-in-review summaries for various projects. It includes no financial statements or detailed financial performance data typical of annual or interim reports. The presence of the term 'AGM' and the nature of the content focusing on company updates, management, and strategic highlights strongly indicate this is material prepared for an Annual General Meeting. The document length is substantial (15,000 characters), consistent with a presentation rather than a brief announcement or regulatory filing. Therefore, the document fits the category of AGM Information (AGM-R).
2022-11-16 English
Results of Meeting 3 pages 168.7KB
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an ASX announcement titled 'RESULTS OF ANNUAL GENERAL MEETING' for Imugene Limited dated 17 November 2022. It details the voting results for various resolutions at the AGM, including proxy votes and poll results. The content focuses exclusively on the outcomes of shareholder votes at the AGM and does not contain financial statements, management discussion, or other report content. The document length is 5561 characters, which is sufficient to include detailed voting results but does not constitute a full report. Therefore, this document is best classified as a Declaration of Voting Results & Voting Rights Announcements (DVA).
2022-11-16 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.